Sign In
Buy CELC
$88.95
-2.47 (-2.70%)
At Close: Jun 03, 2026
ARK Genomic Revolution Multi-Sector ETF: An Overbought But Promising Niche Play
02:10pm, Friday, 08'th May 2020
I am neutral on ARKG, an exciting, niche biotech ETF that currently looks overbought on the charts. I expect investor interest in this space to stay elevated on
Celcuity Reports First Quarter 2020 Financial Results and Recent Business Highlights
08:00pm, Thursday, 07'th May 2020
Significant progress made in development of new, highly precise diagnostics using proprietary CELsignia platform Expect to announce new clinical trial collaborations with pharmaceutical companies and
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
12:00am, Thursday, 07'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 6.)
Adverum Biotechnologies Inc...
May 05, 2020 Xherald --
Veterinary Reference Laboratory (VRL) Market report will make detailed analysis mainly on in-depth research on the development...
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
Roche Q1 Sales Call Key Takeaways
12:39pm, Tuesday, 28'th Apr 2020
We highlight main points from Roche Q1 conference call and summarize key takeaways for investors. Pharma is showing resilience in the face of intensive biosimil
Celcuity Inc. Schedules Release of First Quarter 2020 Financial Results and Conference Call
08:40pm, Thursday, 23'rd Apr 2020
MINNEAPOLIS, MN / ACCESSWIRE / April 23, 2020 / Celcuity Inc. (CELC), a functional cellular analysis company that is developing companion diagnostic tests designed to expand the eligible patient popul
'A disaster': Roche CEO's verdict on some COVID-19 antibody tests
07:35pm, Wednesday, 22'nd Apr 2020
Some blood tests being marketed to tell people if they have had the new coronavirus are a "disaster", Roche Chief Executive Severin Schwan said on Wednesday as he prepares to launch the drugmaker's ow
Roche décoiffe les attentes au premier trimestre 2020
04:11pm, Wednesday, 22'nd Apr 2020
La croissance a été alimentée par la principale division Pharmaceuticals, dont les revenus ont progressé de 3% à 12,26 milliards. L'action a clôturé en nette hausse.
The Daily Biotech Pulse: Moderna Secures $483M In BARDA Funding, Gilead Remdesivir Data, Veracyte's Positive Pre-Announcement
11:35am, Friday, 17'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 16.) * Abbott Laboratories (NYSE: ABT) (reacted to firs
The Daily Biotech Pulse: Genmark Pre-Announces Q1 Outperformance, Sage to Eliminate 53% of Workforce, Keros IPO
11:53am, Wednesday, 08'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 7) * Dr.Reddy's Laboratories Ltd (NYSE: RDY) * Masimo C
Here's Why We're Not Too Worried About Celcuity's (NASDAQ:CELC) Cash Burn Situation
01:23pm, Tuesday, 07'th Apr 2020
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
The Daily Biotech Pulse: Fate Therapeutics Inks Cell Therapy Deal With J&J, Zentalis IPO
11:36am, Friday, 03'rd Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 2)BELLUS Health Inc (NASDAQ: BLU)Down In The Dumps (Biote
The Daily Biotech Pulse: Fate Therapeutics Inks Cell Therapy Deal With J&J, Zentalis IPO
12:00am, Friday, 03'rd Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs April 2)
BELLUS Health Inc (NASDAQ:...
Coronavirus Scare Supports These Biotech ETFs & Stocks
12:00am, Tuesday, 24'th Mar 2020
Stocks Analysis by Zacks Investment Research covering: S&P 500, Dow Jones Industrial Average, Gilead Sciences Inc, Biogen Inc. Read Zacks Investment Research's latest article on Investing.com
